Stronger Sell Today ALNY ranks #4497 as SELL CANDIDATE. Weaker Sell
Today ALNY ranks #4497 as SELL CANDIDATE.

ALNY stock Alnylam Pharmaceuticals

ALNY stock
Alnylam Pharmaceuticals

April 24, 2019
Change -2.33%
Chart period: 2019-01-25 - 2019-04-24
VOLUME
Sell
TREND
Buy

MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Sell

Will ALNY stock price go up or down on Thu, 25 Apr 2019?

Alnylam Pharmaceuticals Forecast and Stock Analysis

Technical ALNY stock analysis for April 24, 2019.

Sell candidate since 2019-04-17 Gain 0.57%
Shorts n/a
Cash n/a
Loans n/a
Beta 2.52
ROA -43.71

Alnylam Pharmaceuticals fell by -2.33% in the last day from $87.41 to $85.37 The price has been going up and down for this period, and there has been a -3.98% loss for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -261 235 shares and in total 335 317 shares bought and sold for approximately $28.63 million.

Close price at the end of the last trading day (Wednesday, 24th Apr 2019) of the ALNY stock was $85.37. This is 2.33% less than the trading day before Tuesday, 23rd Apr 2019.

During day the stock fluctuated 3.14% from a day low at $84.67 to a day high of $87.33.

30 day high of the ALNY stock price was $96.08 and low was $79.79.
90 day high was $96.08 and low was $74.29.
52 week high for the Alnylam Pharmaceuticals - $124.22 and low - $60.27.

Trend

Alnylam Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 11.09% during the next 3 months and, with 90% probability hold a price between $91.70 and $107.01 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Alnylam Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $85.71 and $88.34. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday April 23, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 38 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Alnylam Pharmaceuticals finds support from accumulated volume at $85.00.

Support: $85.00 Price: $85.37 Resistance: $90.17

Risk

This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $2.66 (3.14%) between high and low. For the last week, the stock has had a daily average volatility of 5.85%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Stronger Sell Today ALNY ranks #4497 as SELL CANDIDATE. Weaker Sell
Today ALNY ranks #4497 as SELL CANDIDATE.